April 23, 2025 04:14 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Navy officer, IB personnel among 27 killed in Pahalgam terror attack; Amit Shah reaches Srinagar | 'Thoughts and prayers with people of India': JD Vance condoles deaths in J&K terror strike | At least 27 killed in Pahalgam terror attack in Kashmir, Amit Shah leaves for Srinagar | 'Resume teaching without worrying': Mamata Banerjee to job losers camped outside SSC office | A great leader: JD Vance praises Modi after meeting him in New Delhi | ED summons southern superstar Mahesh Babu for questioning in money laundering case | Woman found dead with throat slit, ankles severed in Rajasthan's Sawai Madhopur; sparks outrage | Pope Francis, first Latin-American head of Catholic church, dies at 88 | Murshidabad violence: Supreme Court slams petitioner over irresponsible averments in plea | Family of Murshidabad riots victims decline Mamata Banerjee's compensation
India-Canada
Image Credit: Covishield Twitter handle

India commits to ship Covishield vaccines to Canada within a month

| @indiablooms | Feb 16, 2021, at 04:46 am

Canada/IBNS: Adar Poonawalla, the chief executive of Serum Institute of India (SII), confirmed on Monday that Covishield vaccines would be shipped to Canada within a month.

"As we await regulatory approvals from Canada, I assure you, @SerumInstIndia will fly out #COVISHIELD to Canada in less than a month; I'm on it!" Poonawalla said in a tweet, using the brand name under which Serum produces the shot developed by Oxford University and AstraZeneca Plc.

Earlier, Canada's Prime Minister Justin Trudeau had also been assured by India's Prime Minister Narendra Modi during their discussion on Monday, that India would do its best to supply COVID-19 vaccines sought by Canada.

"Minister Anand continues to make every effort to ensure that vaccines are delivered to Canada as early as possible from a diverse range of suppliers. We will announce details of any agreement once it is finalized," said James Fitz-Morris in an email.

Approval of two separate applications for a vaccine developed by AstraZeneca and Oxford University researchers, including a joint pitch from SII, a private enterprise in Pune in western India, is being reviewed by Health Canada.

Canada has a deal with AstraZeneca for 20 million doses.

(Reporting by Asha Bajaj)
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu